Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Prospera Financial Services Inc

Prospera Financial Services Inc boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 264.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,238 shares of the medical equipment provider's stock after buying an additional 12,510 shares during the quarter. Prospera Financial Services Inc's holdings in Intuitive Surgical were worth $8,468,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at about $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares during the period. LRI Investments LLC acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. Finally, LGT Financial Advisors LLC boosted its position in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 54 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $5.62 during trading on Tuesday, reaching $537.26. The company's stock had a trading volume of 413,184 shares, compared to its average volume of 1,455,744. The company has a market capitalization of $191.36 billion, a price-to-earnings ratio of 86.31, a P/E/G ratio of 5.19 and a beta of 1.39. The stock's 50-day moving average price is $500.33 and its 200 day moving average price is $459.58. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $544.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now owns 1,595 shares of the company's stock, valued at approximately $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock worth $45,897,071 in the last 90 days. Corporate insiders own 0.80% of the company's stock.

Analyst Ratings Changes

A number of research firms recently weighed in on ISRG. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Leerink Partners boosted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.